#Recurrrent C. diff. Clinical Trials
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
The Tumblr office adopted Tommy, an 11-year-old Pomeranian.
Text
Two UK Researchers, Prof.Alistair Leanord and Dr. David Enoch, Present CDI Data At the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Two UK Researchers, Prof.Alistair Leanord and Dr. David Enoch, Present CDI Data At the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Repeated infection with the bacterium Clostridium difficile (C. difficile, C.diff.), which causes abdominal pain, fever, diarrhea is linked to higher death rates, as well as having a significant impact on health services in terms of cost and hospital beds occupied.
In the first of two presentations at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)(tomorrow…
View On WordPress
#Antibiotic awareness#Antibiotic resistance#C. diff. treatments#C. difficile in UK#C. difficile treatments#Clostridium difficile Clincial Trials#Clostridium difficile in the UK#Clostridium difficile treatments#Dr David Enoch#ECCMID#Glasgow University UK#Professor Alistair Leanord#Recurrrent C. diff. Clinical Trials
0 notes
Text
Rebiotix Reports Topline Results From a Controlled Open-label Phase 2 Trial of RBX2660 (PUNCH™ Open Label) For the Prevention of Recurrent Clostridium difficile (C. diff.) Infection (rCDI)
Rebiotix Reports Topline Results From a Controlled Open-label Phase 2 Trial of RBX2660 (PUNCH™ Open Label) For the Prevention of Recurrent Clostridium difficile (C. diff.) Infection (rCDI)
In The News
April 2017
Rebiotix Inc., a clinical-stage microbiome company focused on harnessing the power of the human microbiome to treat challenging diseases, today announced topline results from a controlled open-label Phase 2 trial of RBX2660 (PUNCH™ Open Label) for the prevention of recurrent Clostridium difficile (C. diff.) infection.
Data indicated that RBX2660 was well-tolerated and…
View On WordPress
#C Diff Clinical Trials#Clostridium diffiicle Clinical Trials#Microbiota restoration therapy#MRT#Rebiotix#Rebiotix C. difficile RBX2660 study#Recurrent C diff Infection#Recurrent C. diff. Prevention#Recurrent C. diff. Prevention Clinical Trial#Recurrent C. difficile Infection Clinical Trials#Recurrrent C. diff. Clinical Trials
0 notes